Details for New Drug Application (NDA): 020233
✉ Email this page to a colleague
NDA 020233 describes RHINOCORT, which is a drug marketed by Astrazeneca and Kenvue Brands and is included in two NDAs. Additional details are available on the RHINOCORT profile page.
The generic ingredient in RHINOCORT is budesonide. There is one drug master file entry for this compound. Forty suppliers are listed for this compound. Additional details are available on the budesonide profile page.
The generic ingredient in RHINOCORT is budesonide. There is one drug master file entry for this compound. Forty suppliers are listed for this compound. Additional details are available on the budesonide profile page.
Summary for 020233
| Tradename: | RHINOCORT |
| Applicant: | Astrazeneca |
| Ingredient: | budesonide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020233
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | AEROSOL, METERED;NASAL | Strength | 0.032MG/INH | ||||
| Approval Date: | Feb 14, 1994 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
